tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HK:9966 Stock Latest News

Alphamab Oncology Gains Approval for Key Cancer Trial
Company AnnouncementsAlphamab Oncology Gains Approval for Key Cancer Trial
24d ago
9966
Alphamab Oncology Receives Approval for JSKN033 Clinical Trial
PremiumCompany Announcements
Alphamab Oncology Receives Approval for JSKN033 Clinical Trial
27d ago
9966
Alphamab Oncology’s Promising Trial Results Bolster Prospects
PremiumCompany Announcements
Alphamab Oncology’s Promising Trial Results Bolster Prospects
2M ago
9966
Alphamab Oncology Granted Waiver for Key Appointment
PremiumCompany Announcements
Alphamab Oncology Granted Waiver for Key Appointment
3M ago
9966
Alphamab Oncology Grants Share Options to Employees
PremiumCompany Announcements
Alphamab Oncology Grants Share Options to Employees
3M ago
9966
Alphamab Oncology Strengthens Leadership with New Appointments
PremiumCompany AnnouncementsAlphamab Oncology Strengthens Leadership with New Appointments
3M ago
9966
Alphamab Oncology Unveils Board Structure and Strategy
Premium
Company Announcements
Alphamab Oncology Unveils Board Structure and Strategy
3M ago
9966
Alphamab Oncology Partners with CSPC on Cancer Drug
Premium
Company Announcements
Alphamab Oncology Partners with CSPC on Cancer Drug
4M ago
9966
Alphamab Oncology’s Drug Shows Promise in Clinical Studies
PremiumCompany Announcements
Alphamab Oncology’s Drug Shows Promise in Clinical Studies
4M ago
9966
Alphamab Oncology’s KN046 Trial Shows Promising Results
PremiumCompany Announcements
Alphamab Oncology’s KN046 Trial Shows Promising Results
4M ago
9966
Alphamab Oncology Extends Suzhou Lease Agreement
PremiumCompany Announcements
Alphamab Oncology Extends Suzhou Lease Agreement
5M ago
9966
Alphamab Oncology Advances Despite Losses
PremiumCompany Announcements
Alphamab Oncology Advances Despite Losses
5M ago
9966
Alphamab Oncology Commits to Share Buyback Strategy
PremiumCompany AnnouncementsAlphamab Oncology Commits to Share Buyback Strategy
5M ago
9966
Alphamab Oncology Schedules Key Financial Meeting
Premium
Company Announcements
Alphamab Oncology Schedules Key Financial Meeting
6M ago
9966
Alphamab Oncology Shareholders Approve Key Resolutions
Premium
Company Announcements
Alphamab Oncology Shareholders Approve Key Resolutions
7M ago
9966
Alphamab Oncology Partners with ArriVent
PremiumCompany Announcements
Alphamab Oncology Partners with ArriVent
8M ago
9966
Alphamab Oncology Reports Promising Trial Results
PremiumCompany Announcements
Alphamab Oncology Reports Promising Trial Results
8M ago
9966
Alphamab Oncology’s KN046 Trial Misses Endpoint
PremiumCompany Announcements
Alphamab Oncology’s KN046 Trial Misses Endpoint
8M ago
9966
Alphamab Oncology Begins Pioneering Cancer Drug Trial
PremiumCompany Announcements
Alphamab Oncology Begins Pioneering Cancer Drug Trial
8M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >